World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
27125
World Ranking
13668
National Ranking
6942

Overview

Michael Becker is affiliated with the University of Chicago in the United States. Their academic focus spans multiple disciplines, with a predominant presence in Medicine and Social Sciences. More specifically, Becker's work concentrates on subfields such as Political Science and International Relations, Hematology, Sociology and Political Science, Surgery, and Biomedical Engineering.

The main research topics covered by Becker include:

  • International Law and Human Rights
  • Hematopoietic Stem Cell Transplantation
  • European and International Law Studies
  • Global Peace and Security Dynamics
  • Asian Geopolitics and Ethnography
  • Jewish and Middle Eastern Studies
  • International Arbitration and Investment Law

The scholar has published extensively in a range of academic journals. Frequent publication venues include:

  • SSRN Electronic Journal
  • Transplantation and Cellular Therapy
  • Cancer Research
  • Acta Crystallographica Section A Foundations and Advances
  • Arthritis & Rheumatology

Some notable recent papers by Becker are:

  • "Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial" (2022, Arthritis & Rheumatology)
  • "The Plight of the Rohingya: Genocide Allegations and Provisional Measures in The Gambia v Myanmar at the International Court of Justice" (2020, SSRN Electronic Journal)
  • "Relevance of Costovertebral Exarticulation of the First Rib in Neurogenic Thoracic Outlet Syndrome: A Retrospective Clinical Study" (2023, Journal of Personalized Medicine)
  • "Chromosomal segregation analysis and HOST-based sperm selection in a complex reciprocal translocation carrier" (2022, Journal of Assisted Reproduction and Genetics)
  • "Crisis in Gaza: South Africa v Israel at the International Court of Justice (or the Unbearable Lightness of Provisional Measures)" (2024, SSRN Electronic Journal)

In the realm of book publications, Becker has one title published by Mohr Siebeck eBooks: Kriegsrecht im frühneuzeitlichen Protestantismus (2020).

Frequent collaborators in Becker's research include:

  • Jane L. Liesveld
  • Eric Huselton
  • Omar S. Aljitawi
  • David J. Kissick
  • Robert F. Fischetti

Best Publications

  • Febuxostat compared with allopurinol in patients with hyperuricemia and gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis

    H Witt;W Luck;H C Hennies;M Classen

  • Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

    William B. White;Kenneth G. Saag;Michael A. Becker;Jeffrey S. Borer

  • Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

    H. Ralph Schumacher;H. Ralph Schumacher;Michael A. Becker;Robert L. Wortmann;Patricia A. MacDonald

  • Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range.

    Thomas H. Marwick;Rodel L. Leano;Joseph Brown;Jing Ping Sun

  • The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

    Michael A Becker;H Ralph Schumacher;Luis R Espinoza;Alvin F Wells

  • Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment: Two Randomized Controlled Trials

    John S. Sundy;Herbert S. B. Baraf;Robert A. Yood;N. Lawrence Edwards

  • Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.

    Yasuhiro Takano;Kumiko Hase-Aoki;Hideki Horiuchi;Lin Zhao

  • Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Sheng Li;Francine E Garrett-Bakelman;Stephen S Chung;Mathijs A Sanders

  • Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

    Richard Furie;William Stohl;Ellen M Ginzler;Michael Becker

  • A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis

    Heiko Witt;Werner Luck;Michael Becker

  • Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

    Iduna Fichtner;Jana Rolff;Richie Soong;Jens Hoffmann

  • Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

    Michael A Becker;H Ralph Schumacher;Patricia A MacDonald;Eric Lloyd

  • Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

    H. R. Schumacher;M. A. Becker;E. Lloyd;P. A. MacDonald

  • Analysis of myocardial deformation based on pixel tracking in two dimensional echocardiographic images enables quantitative assessment of regional left ventricular function

    Michael Becker;Eva Bilke;Harald Kühl;Markus Katoh

  • Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

    Moritz Schütte;Thomas Risch;Nilofar Abdavi-Azar;Karsten Boehnke

  • Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.

    Gary E. Weissman;Andrew Crane-Droesch;Corey Chivers;Thai Binh Luong

  • A degradation-sensitive anionic trypsinogen ( PRSS2 ) variant protects against chronic pancreatitis

    Heiko Witt;Miklós Sahin-Tóth;Olfert Landt;Jian Min Chen

  • Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.

    Matthew D. Linnik;Jay Z. Hu;Kenneth R. Heilbrunn;Vibeke Strand

Frequent Co-Authors

Nikolaus Marx
Nikolaus Marx RWTH Aachen University
Malte Kelm
Malte Kelm Heinrich Heine University Düsseldorf
H. Ralph Schumacher
H. Ralph Schumacher University of Pennsylvania
Theodore Alexandrov
Theodore Alexandrov European Molecular Biology Laboratory
Rainer F. Mahrt
Rainer F. Mahrt IBM (United States)
Laurence Meyer
Laurence Meyer University of Utah
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Nicola Dalbeth
Nicola Dalbeth University of Auckland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to diverse health-related fields beyond the traditional MD pathway. For those interested in diet and wellness, exploring an online degree nutrition program can lead to rewarding opportunities in healthcare and public health settings.

If advancing to leadership roles in healthcare management is your goal, accredited online programs can offer flexibility. Consider enrolling in one of the online mha programs cahme accredited, which meet rigorous industry standards and prepare graduates for executive positions.

Registered nurses seeking to enhance their qualifications often ask: does rn to bsn require clinicals? Many online RN to BSN programs now offer flexible options, some even without in-person clinical requirements, making career advancement more accessible than ever.

For nurses aspiring to the highest level of practice, dnp programs online can be completed in a short time frame, allowing quicker entry into advanced practice and leadership positions.

These online pathways provide flexible, accredited options for building your healthcare career—whatever your focus or current experience level.

Best Scientists Citing Michael Becker

Trending Scientists

Recently Published Articles